These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19410012)

  • 1. Navigating structure-activity landscapes.
    Bajorath J; Peltason L; Wawer M; Guha R; Lajiness MS; Van Drie JH
    Drug Discov Today; 2009 Jul; 14(13-14):698-705. PubMed ID: 19410012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances.
    Peltason L; Bajorath J
    Future Med Chem; 2009 Jun; 1(3):451-66. PubMed ID: 21426126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global mapping of pharmacological space.
    Paolini GV; Shapland RH; van Hoorn WP; Mason JS; Hopkins AL
    Nat Biotechnol; 2006 Jul; 24(7):805-15. PubMed ID: 16841068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale SAR analysis.
    Bajorath J
    Drug Discov Today Technol; 2013 Sep; 10(3):e419-26. PubMed ID: 24050139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazole CCK(1) receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free-Wilson additivity.
    McClure K; Hack M; Huang L; Sehon C; Morton M; Li L; Barrett TD; Shankley N; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Jan; 16(1):72-6. PubMed ID: 16236513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazole CCK(1) receptor antagonists. Part 2: SAR studies by solid-phase library synthesis and determination of Free-Wilson additivity.
    Sehon C; McClure K; Hack M; Morton M; Gomez L; Li L; Barrett TD; Shankley N; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Jan; 16(1):77-80. PubMed ID: 16236506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation and application of activity discriminants in lead optimization.
    Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
    J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets.
    Dimova D; Heikamp K; Stumpfe D; Bajorath J
    J Med Chem; 2013 Apr; 56(8):3339-45. PubMed ID: 23527828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular similarity measures.
    Maggiora GM; Shanmugasundaram V
    Methods Mol Biol; 2011; 672():39-100. PubMed ID: 20838964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data structures and computational tools for the extraction of SAR information from large compound sets.
    Wawer M; Lounkine E; Wassermann AM; Bajorath J
    Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraction of discontinuous structure-activity relationships from compound data sets through particle swarm optimization.
    Namasivayam V; Iyer P; Bajorath J
    J Chem Inf Model; 2011 Jul; 51(7):1545-51. PubMed ID: 21644503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices.
    Wawer M; Peltason L; Weskamp N; Teckentrup A; Bajorath J
    J Med Chem; 2008 Oct; 51(19):6075-84. PubMed ID: 18798611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data.
    Muresan S; Petrov P; Southan C; Kjellberg MJ; Kogej T; Tyrchan C; Varkonyi P; Xie PH
    Drug Discov Today; 2011 Dec; 16(23-24):1019-30. PubMed ID: 22024215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From magic bullets to designed multiple ligands.
    Morphy R; Kay C; Rankovic Z
    Drug Discov Today; 2004 Aug; 9(15):641-51. PubMed ID: 15279847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSRR: quantitative structure-(chromatographic) retention relationships.
    Kaliszan R
    Chem Rev; 2007 Jul; 107(7):3212-46. PubMed ID: 17595149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.